Eli Lilly and Co LLY
Valuation
Multiples measured against the stock's own five-year history
Below its usual level · 27th percentile, 5-year average 67.6x
#2504 of 2972 stocks by PE (1 = cheapest)
Below its usual level · 25th percentile, 5-year average 43.0x
#5195 of 5311 stocks by PB (1 = cheapest)
Around its usual level · 57th percentile, 5-year average 15.1x
#4637 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 33.11 | – | 43.00 | 25% (cheaper than usual) | #5195 of 5311 (1 = cheapest) |
| PE | 46.01 | 33.03 | 67.60 | 27% (cheaper than usual) | #2504 of 2972 (1 = cheapest) |
| PS | 15.42 | 13.53 | 15.09 | 57% (pricier than usual) | #4637 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on LLY.
Sign in to join the discussion.